CBLL (CeriBell) Insider Ownership : 4.51 % (As of Dec. 14, 2024)

View and export this data going back to 2024. Start your Free Trial

What is CeriBell Insider Ownership?

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, CeriBell's insider ownership is 4.51%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, CeriBell's Institutional Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, CeriBell's Float Percentage Of Total Shares Outstanding is 0.00%.

CeriBell Insider Ownership Historical Data

The historical data trend for CeriBell's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CeriBell Insider Ownership Chart

CeriBell Historical Data

The historical data trend for CeriBell can be seen below:

	2024-10-31	2024-11-30
Insider Ownership	4.53	4.51

CeriBell Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.

CeriBell Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CeriBell Inc (NAS:CBLL) » Definitions » Insider Ownership

Comparable Companies

Traded in Other Exchanges

N/A

Address

360 N. Pastoria Avenue, Sunnyvale, CA, USA, 94085

Website

https://www.ceribell.com

CeriBell Inc is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, highly portable and rapidly deployable hardware with sophisticated artificial intelligence (AI) powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions.